Full name: Marina Magrey
Current country: United States
Membership level: Full
Type of membership: Member
Number of publications: 12
Psychosocial burden of axial spondyloarthritis and impact of different disease domains: a systematic literature review. Rheumatol Adv Pract. 2025 May 26;9(3):rkaf063. doi: 10.1093/rap/rkaf063. PMID: 40584930; PMCID: PMC12202762. Copy .nbib For (2025)
https://pubmed.ncbi.nlm.nih.gov/40584930
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2 (2024)
https://pubmed.ncbi.nlm.nih.gov/38599650
Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors (2023)
https://doi.org/10.1007/s10067-023-06776-5
Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis (2023)
https://doi.org/10.1016/j.jbspin.2023.105625
Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study (2023)
https://doi.org/10.1136%2Frmdopen-2023-003179
Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis (2023)
https://doi.org/10.1016/j.jbspin.2023.105625
Prevalence and distribution of peripheral muculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/
Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/33105312/
Understanding Barriers in the Pathway to Diagnosis of Ankylosing Spondylitis: Results From a US Survey of 1690 Physicians From 10 Specialties (2020)
https://pubmed.ncbi.nlm.nih.gov/33029932/
Recognizing Axial Spondyloarthritis: A Guide for Primary Care (2020)
https://pubmed.ncbi.nlm.nih.gov/32736944/
The American College of Rheumatology Fibromyalgia Criteria Are Useful in the Evaluation of Fibromyalgia Symptoms in Patients With Ankylosing Spondylitis: A Cross-Sectional Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32701537/
Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial (2020)
https://pubmed.ncbi.nlm.nih.gov/33044756/